High avidity antigen-specific CTL identified by CD8-independent tetramer staining
- PMID: 14607910
- DOI: 10.4049/jimmunol.171.10.5116
High avidity antigen-specific CTL identified by CD8-independent tetramer staining
Abstract
Tetrameric MHC/peptide complexes are important tools for enumerating, phenotyping, and rapidly cloning Ag-specific T cells. It remains however unclear whether they can reliably distinguish between high and low avidity T cell clones. In this report, tetramers with mutated CD8 binding site selectively stain higher avidity human and murine CTL capable of recognizing physiological levels of Ag. Furthermore, we demonstrate that CD8 binding significantly enhances the avidity as well as the stability of interactions between CTL and cognate tetramers. The use of CD8-null tetramers to identify high avidity CTL provides a tool to compare vaccination strategies for their ability to enhance the frequency of high avidity CTL. Using this technique, we show that DNA priming and vaccinia boosting of HHD A2 transgenic mice fail to selectively expand large numbers of high avidity NY-ESO-1(157-165)-specific CTL, possibly due to the large amounts of antigenic peptide delivered by the vaccinia virus. Furthermore, development of a protocol for rapid identification of high avidity human and murine T cells using tetramers with impaired CD8 binding provides an opportunity not only to monitor expansion of high avidity T cell responses ex vivo, but also to sort high avidity CTL clones for adoptive T cell transfer therapy.
Similar articles
-
Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.J Immunol. 2000 Dec 15;165(12):7253-61. doi: 10.4049/jimmunol.165.12.7253. J Immunol. 2000. PMID: 11120859
-
Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.J Immunol. 1999 Feb 15;162(4):2227-34. J Immunol. 1999. PMID: 9973498
-
Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans.J Immunol. 2000 Dec 1;165(11):6463-71. doi: 10.4049/jimmunol.165.11.6463. J Immunol. 2000. PMID: 11086086
-
The use of chimeric A2K(b) tetramers to monitor HLA A2 immune responses in HLA A2 transgenic mice.J Immunol Methods. 2002 Oct 1;268(1):35-41. doi: 10.1016/s0022-1759(02)00198-9. J Immunol Methods. 2002. PMID: 12213341 Review.
-
Molecular mechanisms and biological significance of CTL avidity.Curr HIV Res. 2003 Jul;1(3):287-94. doi: 10.2174/1570162033485230. Curr HIV Res. 2003. PMID: 15046253 Review.
Cited by
-
MHC class I molecules with Superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLs.J Immunol. 2010 Apr 1;184(7):3357-66. doi: 10.4049/jimmunol.0902398. Epub 2010 Feb 26. J Immunol. 2010. PMID: 20190139 Free PMC article.
-
Interrogating the repertoire: broadening the scope of peptide-MHC multimer analysis.Nat Rev Immunol. 2011 Jul 15;11(8):551-8. doi: 10.1038/nri3020. Nat Rev Immunol. 2011. PMID: 21760610 Free PMC article. Review.
-
Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide.J Immunother Cancer. 2021 Jun;9(6):e002544. doi: 10.1136/jitc-2021-002544. J Immunother Cancer. 2021. PMID: 34088742 Free PMC article.
-
More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers.Immunology. 2015 Sep;146(1):11-22. doi: 10.1111/imm.12499. Immunology. 2015. PMID: 26076649 Free PMC article. Review.
-
Dual Molecular Mechanisms Govern Escape at Immunodominant HLA A2-Restricted HIV Epitope.Front Immunol. 2017 Nov 10;8:1503. doi: 10.3389/fimmu.2017.01503. eCollection 2017. Front Immunol. 2017. PMID: 29209312 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
